ArticleInternational journal of geriatric psychiatry2026
The Relationship Between Polygenic Risk of Depression and Regional Brain Atrophy in Older Adults.
Article in International journal of geriatric psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundDepression has been identified as a risk factor for the development of dementia, but the relationship between the two conditions is complex. If the mechanism by which depression increased the risk of dementia was better understood then new treatment targets could be identified. Previous studies have found evidence of reduced hippocampal volume in depressed patients, but because depression may also be an early sign of dementia, these studies may have inadvertently included individuals in the early stages of dementia. We used genetic risk of depression as our exposure and examined whether older adults with the highest genetic risk of depression had reduced regional brain volumes or greater longitudinal regional atrophy.
methodsWe used clinical, genetic and neuroimaging data from the ROSMAP and ADNI studies, which are both older adult focused longitudinal cohort studies with derived regional brain volumes a subset of available from MRI scans. Polygenic scores for depression were generated in PLINK from genotyped data imputed using 1000 genomes Phase 3 v5 using the clumping and thresholding method, based on the Howard et al., 2019 GWAS of depression. In ADNI n = 473 at baseline and 342 at 12 months, in ROSMAP n = 187 at baseline and n = 113 at 12 months. In a secondary analysis we excluded those with dementia at baseline. Our primary outcome was the effect of PRS-D on hippocampal volume in both studies using linear regression. The results from the 2 studies were then meta-analysed.
resultsWe did not find any evidence of an effect of polygenic risk for depression on regional brain volume changes at baseline or after 12 months, either in ROSMAP or ADNI individually or in the meta-analysis. This finding was not affected by excluding individuals with evidence of dementia at baseline in ADNI or in ROSMAP those with AD at post-mortem examination.
conclusionsWe found no strong evidence of an effect of polygenic risk of depression on regional brain volumes in older adults either at baseline or after 12 months. Our work was limited to genetic risk of depression and further research is required to investigate the complex relationship between depression and dementia.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.